{"id":837318,"date":"2025-04-15T08:05:28","date_gmt":"2025-04-15T12:05:28","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/organon-to-report-first-quarter-2025-results-and-host-conference-call-on-may-1-2025\/"},"modified":"2025-04-15T08:05:28","modified_gmt":"2025-04-15T12:05:28","slug":"organon-to-report-first-quarter-2025-results-and-host-conference-call-on-may-1-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/organon-to-report-first-quarter-2025-results-and-host-conference-call-on-may-1-2025\/","title":{"rendered":"Organon To Report First Quarter 2025 Results and Host Conference Call on May 1, 2025"},"content":{"rendered":"

<\/p>\n

Organon To Report First Quarter 2025 Results and Host Conference Call on May 1, 2025<\/b><\/p>\n

JERSEY CITY, N.J.–(BUSINESS WIRE<\/a>)–
\nOrganon (NYSE: OGN), a global healthcare company with a primary focus on women\u2019s health, will release its first quarter 2025 financial results on May 1, 2025, prior to the company\u2019s webcast and conference call scheduled for 8:30 a.m. EDT.\n<\/p>\n

IPR&D and Milestones<\/b><\/p>\n

\nOrganon currently expects that it will record approximately $6 million of milestone expense in the first quarter of 2025.\n<\/p>\n

\nOrganon does not forecast IPR&D (in process research and development) or milestones due to the level of uncertainty and ability to forecast the timing of such achievements. As such, these milestones, as well as any future IPR&D and milestones are not contemplated in the company\u2019s financial guidance provided on February 13, 2025. Organon\u2019s first quarter 2025 results have not been finalized and are subject to the company\u2019s quarterly financial statement closing procedures. There can be no assurance that actual results will not differ from the preliminary estimates described herein.\n<\/p>\n

Accessing First Quarter 2025 Financial Results Webcast<\/b><\/p>\n

\nInterested parties may access the live call via webcast on the Organon website at https:\/\/www.organon.com\/investor-relations\/events-and-presentations\/<\/a>. A replay of the webcast will be available approximately two hours after the conclusion of the live event on the company\u2019s website.\n<\/p>\n

\nInstitutional investors and analysts interested in participating in the call must register in advance by clicking on this link https:\/\/registrations.events\/direct\/Q4I585113<\/a><\/p>\n

\nFollowing registration, participants will receive a confirmation email containing details on how to join the conference call, including dial-in information and a unique passcode and registrant ID. Pre-registration will allow participants to bypass an operator and be placed directly into the call.\n<\/p>\n

About Organon<\/b><\/p>\n

Organon<\/a> is an independent global healthcare company with a mission to help improve the health of women throughout their lives. Organon\u2019s diverse portfolio offers over 70 medicines and products in women\u2019s health, biosimilars, and a large franchise of established medicines across a range of therapeutic areas. In addition to Organon\u2019s current products, the company invests in innovative solutions and research to drive future growth opportunities in women\u2019s health and biosimilars. Organon is also pursuing opportunities to collaborate with biopharmaceutical partners and innovators who look to commercialize their products by leveraging Organon\u2019s scale and agile presence in fast growing international markets.\n<\/p>\n

\nOrganon has geographic scope with significant reach, world-class commercial capabilities, and approximately 10,000 employees with headquarters located in Jersey City, New Jersey.\n<\/p>\n

\nFor more information, visit http:\/\/www.organon.com<\/a> and connect with us on LinkedIn<\/a>, Instagram<\/a>, X (formerly known as Twitter)<\/a> and Facebook<\/a>.\n<\/p>\n

Cautionary Note Regarding Forward-Looking Statements<\/b><\/p>\n

\nThe information above reflects management\u2019s current intentions and expectations for the future with respect to Organon\u2019s expectations regarding milestone expenses, which constitute \u201cforward-looking statements\u201d within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are subject to a number of risks, assumptions, uncertainties and other factors, such as the completion of Organon\u2019s quarter-end closing process, including review by management and the audit committee of the Organon\u2019s board of directors, which could result in material changes to the preliminary estimates described herein. Organon undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Factors that could cause results to differ materially from those described in the forward-looking statements can be found in Organon\u2019s filings with the Securities and Exchange Commission (“SEC”), including Organon\u2019s most recent Annual Report on Form 10-K and subsequent SEC filings, available at the SEC\u2019s Internet site (www.sec.gov<\/a>).\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20250415758908\/en\/<\/a><\/span><\/p>\n

\nOrganon Media Contacts:\n<\/p>\n

\nFelicia Bisaro
\n
(646) 703-1807\n<\/p>\n

\nKate Vossen
\n
(732) 675-8448\n<\/p>\n

\nOrganon Investor Contacts:\n<\/p>\n

\nJennifer Halchak
\n
(201) 275-2711\n<\/p>\n

\nRenee McKnight
\n
(551) 204-6129\n<\/p>\n

KEYWORDS:<\/b> United States North America New Jersey<\/p>\n

INDUSTRY KEYWORDS:<\/b> Health Consumer Women General Health Pharmaceutical Biotechnology<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Organon To Report First Quarter 2025 Results and Host Conference Call on May 1, 2025 JERSEY CITY, N.J.–(BUSINESS WIRE)– Organon (NYSE: OGN), a global healthcare company with a primary focus on women\u2019s health, will release its first quarter 2025 financial results on May 1, 2025, prior to the company\u2019s webcast and conference call scheduled for 8:30 a.m. EDT. IPR&D and Milestones Organon currently expects that it will record approximately $6 million of milestone expense in the first quarter of 2025. Organon does not forecast IPR&D (in process research and development) or milestones due to the level of uncertainty and ability to forecast the timing of such achievements. As such, these milestones, as well as any future IPR&D and milestones are … <\/p>\n

Continue reading “Organon To Report First Quarter 2025 Results and Host Conference Call on May 1, 2025”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-837318","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nOrganon To Report First Quarter 2025 Results and Host Conference Call on May 1, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/organon-to-report-first-quarter-2025-results-and-host-conference-call-on-may-1-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Organon To Report First Quarter 2025 Results and Host Conference Call on May 1, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Organon To Report First Quarter 2025 Results and Host Conference Call on May 1, 2025 JERSEY CITY, N.J.–(BUSINESS WIRE)– Organon (NYSE: OGN), a global healthcare company with a primary focus on women\u2019s health, will release its first quarter 2025 financial results on May 1, 2025, prior to the company\u2019s webcast and conference call scheduled for 8:30 a.m. EDT. IPR&D and Milestones Organon currently expects that it will record approximately $6 million of milestone expense in the first quarter of 2025. Organon does not forecast IPR&D (in process research and development) or milestones due to the level of uncertainty and ability to forecast the timing of such achievements. As such, these milestones, as well as any future IPR&D and milestones are … Continue reading "Organon To Report First Quarter 2025 Results and Host Conference Call on May 1, 2025"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/organon-to-report-first-quarter-2025-results-and-host-conference-call-on-may-1-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-15T12:05:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250415758908r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/organon-to-report-first-quarter-2025-results-and-host-conference-call-on-may-1-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/organon-to-report-first-quarter-2025-results-and-host-conference-call-on-may-1-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Organon To Report First Quarter 2025 Results and Host Conference Call on May 1, 2025\",\"datePublished\":\"2025-04-15T12:05:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/organon-to-report-first-quarter-2025-results-and-host-conference-call-on-may-1-2025\\\/\"},\"wordCount\":673,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/organon-to-report-first-quarter-2025-results-and-host-conference-call-on-may-1-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250415758908r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/organon-to-report-first-quarter-2025-results-and-host-conference-call-on-may-1-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/organon-to-report-first-quarter-2025-results-and-host-conference-call-on-may-1-2025\\\/\",\"name\":\"Organon To Report First Quarter 2025 Results and Host Conference Call on May 1, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/organon-to-report-first-quarter-2025-results-and-host-conference-call-on-may-1-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/organon-to-report-first-quarter-2025-results-and-host-conference-call-on-may-1-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250415758908r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2025-04-15T12:05:28+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/organon-to-report-first-quarter-2025-results-and-host-conference-call-on-may-1-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/organon-to-report-first-quarter-2025-results-and-host-conference-call-on-may-1-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/organon-to-report-first-quarter-2025-results-and-host-conference-call-on-may-1-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250415758908r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250415758908r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/organon-to-report-first-quarter-2025-results-and-host-conference-call-on-may-1-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Organon To Report First Quarter 2025 Results and Host Conference Call on May 1, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Organon To Report First Quarter 2025 Results and Host Conference Call on May 1, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/organon-to-report-first-quarter-2025-results-and-host-conference-call-on-may-1-2025\/","og_locale":"en_US","og_type":"article","og_title":"Organon To Report First Quarter 2025 Results and Host Conference Call on May 1, 2025 - Market Newsdesk","og_description":"Organon To Report First Quarter 2025 Results and Host Conference Call on May 1, 2025 JERSEY CITY, N.J.–(BUSINESS WIRE)– Organon (NYSE: OGN), a global healthcare company with a primary focus on women\u2019s health, will release its first quarter 2025 financial results on May 1, 2025, prior to the company\u2019s webcast and conference call scheduled for 8:30 a.m. EDT. IPR&D and Milestones Organon currently expects that it will record approximately $6 million of milestone expense in the first quarter of 2025. Organon does not forecast IPR&D (in process research and development) or milestones due to the level of uncertainty and ability to forecast the timing of such achievements. As such, these milestones, as well as any future IPR&D and milestones are … Continue reading \"Organon To Report First Quarter 2025 Results and Host Conference Call on May 1, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/organon-to-report-first-quarter-2025-results-and-host-conference-call-on-may-1-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-04-15T12:05:28+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250415758908r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/organon-to-report-first-quarter-2025-results-and-host-conference-call-on-may-1-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/organon-to-report-first-quarter-2025-results-and-host-conference-call-on-may-1-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Organon To Report First Quarter 2025 Results and Host Conference Call on May 1, 2025","datePublished":"2025-04-15T12:05:28+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/organon-to-report-first-quarter-2025-results-and-host-conference-call-on-may-1-2025\/"},"wordCount":673,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/organon-to-report-first-quarter-2025-results-and-host-conference-call-on-may-1-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250415758908r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/organon-to-report-first-quarter-2025-results-and-host-conference-call-on-may-1-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/organon-to-report-first-quarter-2025-results-and-host-conference-call-on-may-1-2025\/","name":"Organon To Report First Quarter 2025 Results and Host Conference Call on May 1, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/organon-to-report-first-quarter-2025-results-and-host-conference-call-on-may-1-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/organon-to-report-first-quarter-2025-results-and-host-conference-call-on-may-1-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250415758908r1&sid=flmnd&distro=nx&lang=en","datePublished":"2025-04-15T12:05:28+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/organon-to-report-first-quarter-2025-results-and-host-conference-call-on-may-1-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/organon-to-report-first-quarter-2025-results-and-host-conference-call-on-may-1-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/organon-to-report-first-quarter-2025-results-and-host-conference-call-on-may-1-2025\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250415758908r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250415758908r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/organon-to-report-first-quarter-2025-results-and-host-conference-call-on-may-1-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Organon To Report First Quarter 2025 Results and Host Conference Call on May 1, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/837318","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=837318"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/837318\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=837318"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=837318"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=837318"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}